EP Patent

EP1263453A4 — PHARMACEUTICAL FORMULATION FOR REGULATING THE RELEASE IN TIME OF BIOLOGICALLY ACTIVE COMPOUNDS BASED ON A POLYMERIC MATRIX

Assigned to Rutgers State University of New Jersey · Expires 2008-02-20 · 18y expired

What this patent protects

Patent listed against Xiidra.

Drugs covered by this patent

Patent Metadata

Patent number
EP1263453A4
Jurisdiction
EP
Classification
—
Expires
2008-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Rutgers State University of New Jersey
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.